Sylvester O. Agbahiwe PharmD, BCACP

home / authors / sylvester-o-agbahiwe-pharmd-bcacp

Articles

Entresto

Entresto

Sylvester O. Agbahiwe PharmD, BCACP;Oluchi Juliet Emelogu, PharmD Candidate
November 12th 2015

Entresto is a combination of a first-in-class neprilysin inhibitor and an angiotensin receptor blocker indicated for the treatment of heart failure with reduced ejection fraction.

Read More

Kcentra by CSL Behring

Kcentra by CSL Behring

Sylvester O. Agbahiwe PharmD, BCACP;Chika Obi, PharmD Candidate
April 21st 2014

Kcentra is the first nonactivated 4-factor prothrombin complex concentrate for the urgent reversal of acquired coagulation deficiency induced by vitamin K antagonist therapy.

Read More

Site Logo

Kazano by Takeda Pharmaceuticals America, Inc

Sylvester O. Agbahiwe PharmD, BCACP;Chika Obi, PharmD Candidate
February 17th 2014

Read More

Latest Updated Articles

AI patient pharmacist provider interactions ASHP summer
Published: June 11th 2024 | Updated: July 27th 2024
Balancing Trust and Technology: The Role of AI in Patient-Pharmacist Interactions
AI pharmacy futures AI disparities skin
Published: June 11th 2024 | Updated: July 27th 2024
Addressing Disparities in AI-Driven Diagnostics: Ethical and Practical Implications
Vice President Kamala Harris -- Image credit: Erin Schaff/Pool/AFP | GETTY | People.com
Published: July 23rd 2024 | Updated: July 27th 2024
VP Kamala Harris’s Policies and Stances on Health Care, Reproductive Rights Take Center Stage
3d illustration of Abstract medical background with Diseased liver - Image credit: Rasi | stock.adobe.com
Published: October 18th 2023 | Updated: July 27th 2024
Pharmacists Can Optimize Treatment for Patients with NASH, Decreasing Economic Burden
Small vial of influenza vaccine.
Published: July 23rd 2024 | Updated: July 27th 2024
Trivalent Influenza Vaccines Are Readied for Fall
Eye Care Pharmacy | Image Credit: I Viewfinder - stock.adobe.com
Published: July 15th 2024 | Updated: July 27th 2024
Biosimilar Ranibizumab Could be More Cost-Effective Than Aflibercept for nAMD